1Federica Cioffi,Rosalba Senese,Antonia Lanni,Fernando Goglia.Thyroid hormones and mitochondria: With a brief look at derivatives and analogues[J]. Molecular and Cellular Endocrinology . 2013
2A. Mendoza,P. Navarrete-Ramírez,G. Hernández-Puga,P. Villalobos,G. Holzer,J.P. Renaud,V. Laudet,A. Orozco.3,5-T2 Is an Alternative Ligand for the Thyroid Hormone Receptor β1[J]. Endocrinology . 2013 (8)
3Romina Lomonaco,Nishanth E. Sunny,Fernando Bril,Kenneth Cusi.Nonalcoholic Fatty Liver Disease: Current Issues and Novel Treatment Approaches[J]. Drugs . 2013 (1)
4Mohamed Abdellah Ibrahim,Mina Kelleni,Ayman Geddawy.Nonalcoholic fatty liver disease: Current and potential therapies[J]. Life Sciences . 2012
5Ignazio Grattagliano,Ornella de Bari,Telma C. Bernardo,Paulo J. Oliveira,David Q.-H. Wang,Piero Portincasa.Role of mitochondria in nonalcoholic fatty liver disease-from origin to propagation[J]. Clinical Biochemistry . 2012 (9)
6Gabriele V.Gnoni,AlessioRochira,AntonellaLeone,FabrizioDamiano,SantoMarsigliante,LuisaSiculella.3,5,3′triiodo‐L‐thyronine induces SREBP‐1 expression by non‐genomic actions in human HEP G2 cells[J]. J. Cell. Physiol. . 2012 (6)
7Camilla Pramfalk,Matteo Pedrelli,Paolo Parini.Role of thyroid receptor β in lipid metabolism[J]. BBA - Molecular Basis of Disease . 2011 (8)
8Paul J. Davis,Hung-Yun Lin,Shaker A. Mousa,Mary K. Luidens,Aleck A. Hercbergs,Martin Wehling,Faith B. Davis.Overlapping nongenomic and genomic actions of thyroid hormone and steroids[J]. Steroids . 2011 (9)
9Ivan Tancevski,Mats Rudling,Philipp Eller.Thyromimetics: A journey from bench to bed-side[J]. Pharmacology and Therapeutics . 2011 (1)
10Shitalkumar Zambad,Antonia Lanni,Rosanna Busiello,Ram Gupta,Dubey,Munshi,C Dutt,Vijay Chauthaiwale,RC Gupta,Goglia.TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats[J]. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy . 2011 (default)
